What is the recommended protocol for cross-tapering from alprazolam (Xanax) to clonazepam (Klonopin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cross-Tapering from Alprazolam to Clonazepam

The recommended protocol for cross-tapering from alprazolam to clonazepam involves substituting clonazepam at a ratio of 0.5 mg clonazepam for every 1 mg of alprazolam, followed by a gradual taper of clonazepam at a rate of 0.25 mg per week. This approach balances the need to prevent withdrawal symptoms while transitioning between these benzodiazepines effectively.

Cross-Tapering Protocol

Initial Substitution

  • Substitute clonazepam for alprazolam at a ratio of 0.5 mg clonazepam for every 1 mg of alprazolam
  • Example: For a patient on 2 mg daily alprazolam, start with 1 mg daily clonazepam

Stabilization Period

  • Allow 1-2 weeks for stabilization on the initial clonazepam dose
  • Monitor for withdrawal symptoms during this period
  • If withdrawal symptoms occur, consider increasing the clonazepam dose slightly

Clonazepam Tapering Schedule

  • Once stabilized, begin tapering clonazepam by 0.25 mg per week 1
  • For higher doses (>2 mg daily), consider a slower taper of 10% per month
  • Continue until complete discontinuation

Monitoring During Cross-Tapering

Withdrawal Symptoms to Monitor

  • Anxiety, shaking/trembling/tremor
  • Nausea/vomiting, insomnia/nightmares
  • Excessive sweating, tachycardia/palpitations
  • Headache, weakness, muscle aches 1
  • Seizures (rare but serious complication) 2

Adjustments to Tapering Schedule

  • If significant withdrawal symptoms occur, pause the taper and maintain the current dose until symptoms subside
  • Resume tapering at a slower rate if necessary
  • For patients with severe symptoms, consider a "cut and hold" method where dose is reduced and held until withdrawal symptoms subside 3

Clinical Considerations

Advantages of Cross-Tapering with Clonazepam

  • Clonazepam has a longer half-life than alprazolam, making withdrawal symptoms less severe
  • Studies have shown successful detoxification from alprazolam using clonazepam substitution 4, 5
  • True withdrawal syndromes were not observed in studies using clonazepam for alprazolam discontinuation 4

Important Precautions

  • Never discontinue alprazolam abruptly due to risk of withdrawal seizures 2
  • Avoid fixed taper schedules for all patients; adjust based on individual response 3
  • For elderly patients, use a more conservative approach with slower tapering
  • For long-term users (>1 year), consider an even more gradual taper of 10% per month 3

Alternative Approaches

If the standard cross-tapering protocol is not tolerated:

  1. Consider using chlordiazepoxide as an alternative substitution agent (50 mg chlordiazepoxide for each 1 mg alprazolam) 6
  2. For patients with severe withdrawal symptoms, inpatient management may be necessary
  3. Adjunctive medications may help manage specific withdrawal symptoms:
    • Trazodone or mirtazapine for insomnia
    • Propranolol for tachycardia or tremor
    • Cognitive behavioral therapy for anxiety management 3

By following this structured cross-tapering protocol, most patients can successfully transition from alprazolam to clonazepam and ultimately discontinue benzodiazepine therapy with minimal withdrawal symptoms.

References

Research

Benzodiazepine withdrawal seizures and management.

The Journal of the Oklahoma State Medical Association, 2011

Guideline

Medication Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.